IL7 and cancer: The adjuvanticity of IL-7 has been verified to prolong the protective effects of vaccines by inducing the production of memory T and B cells (63–65), highlighting the potential to apply IL-7 as an adjuvant in combination with cancer vaccines to struggle against cancer cells via long-term memory protection.